Healthcare provider profile · identity verified

Nicole Thomas, MD

Family Practice · FOREST HILLS, NY · NPI 1508929563

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	432	164
Amlodipine Besylate	Amlodipine Besylate	241	89
Losartan Potassium	Losartan Potassium	214	83
Metoprolol Succinate	Metoprolol Succinate	207	79
Levothyroxine Sodium	Levothyroxine Sodium	161	61
Lisinopril	Lisinopril	131	44
Simvastatin	Simvastatin	124	42
Metformin Hcl Er	Metformin Hcl	114	37
Metformin Hcl	Metformin Hcl	100	32
Hydrochlorothiazide	Hydrochlorothiazide	92	34
Eliquis	Apixaban	91	33
Gabapentin	Gabapentin	87	43
Furosemide	Furosemide	85	39
Tamsulosin Hcl	Tamsulosin Hcl	81	33
Omeprazole	Omeprazole	77	38
Jardiance	Empagliflozin	74	27
Albuterol Sulfate Hfa	Albuterol Sulfate	72	26
Synthroid	Levothyroxine Sodium	72	23
Rosuvastatin Calcium	Rosuvastatin Calcium	67	32
Pantoprazole Sodium	Pantoprazole Sodium	57	25
Fluticasone Propionate	Fluticasone Propionate	55	32
Carvedilol	Carvedilol	49	19
Ezetimibe	Ezetimibe	47	17
Famotidine	Famotidine	45	20
Allopurinol	Allopurinol	43	13
Montelukast Sodium	Montelukast Sodium	40	13
Valsartan	Valsartan	40	12
Atenolol	Atenolol	38	12
Glimepiride	Glimepiride	38	16
Metoprolol Tartrate	Metoprolol Tartrate	38	16
Farxiga	Dapagliflozin Propanediol	37	15
Januvia	Sitagliptin Phosphate	37	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	11
Ozempic	Semaglutide	36	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	33	11
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Clopidogrel	Clopidogrel Bisulfate	31	12
Finasteride	Finasteride	29	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	12
Donepezil Hcl	Donepezil Hcl	27	suppressed
Glipizide Er	Glipizide	27	12
Alendronate Sodium	Alendronate Sodium	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Trazodone Hcl	Trazodone Hcl	25	suppressed
Chlorthalidone	Chlorthalidone	23	11
Meclizine Hcl	Meclizine Hcl	23	12
Enalapril Maleate	Enalapril Maleate	22	suppressed
Ramipril	Ramipril	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	12
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Mometasone Furoate	Mometasone Furoate	20	16
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	15
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	16	15
Irbesartan	Irbesartan	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	15	suppressed
Dutasteride	Dutasteride	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	14
Novolog Flexpen	Insulin Aspart	14	suppressed
Potassium Chloride	Potassium Chloride	14	suppressed
Sertraline Hcl	Sertraline Hcl	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Hydrocortisone	Hydrocortisone	13	11
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Prednisone	Prednisone	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error